Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions

Immunity

Volumn 11, Issue 6, 1999, Pages 689-698

  Chen, Andy I ^a   McAdam, Alexander J ^a   Buhlmann, Janet E ^a   Scott, Sumi ^a   Lupher Jr , Mark L ^c,e   Greenfield, Edward A ^b   Baum, Peter R ^c   Fanslow, William C ^c   Calderhead, David M ^d,f   Freeman, Gordon J ^b   Sharpe, Arlene H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AMGEN INC   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f Biotransplant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; LIGAND; OXAZOLONE; TUMOR NECROSIS FACTOR DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL STIMULATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; HUMORAL IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033427044     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80143-0     Document Type: Article

References (45)

1. Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
2. Baum, P.R., Gayle, R.B. III, Ramsdell, F., Srinivasan, S., Sorensen, R.A., Watson, M.L., Seldin, M.F., Baker, E., Sutherland, G.R., Clifford, K.N., et al. (1994). Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13, 3992-4001.
3. Borriello, F., Sethna, M.P., Boyd, S.D., Schweitzer, A.N., Tivol, E.A., Jacoby, D., Strom, T.B., Simpson, E.M., Freeman, G.J., and Sharpe, A.M. (1997). B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313.
4. Bour, H., Peyron, E., Gaucherand, M., Garrigue, J.L., Desvignes, C., Kaiserlian, D., Revillard, J.P., and Nicolas, J.F. (1995). Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25, 3006-3010.
5. Bretscher, P.A. (1999). A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. USA 96, 185-190.
6. Calderhead, D.M., Buhlmann, J.E., van den Eertwegh, A.J., Claassen, E., Noelle, R.J., and Fell, H.P. (1993). Cloning of mouse Ox40: A T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151, 5261-5271.
7. Catalina, M.D., Carroll, M.C., Arizpe, H., Takashima, A., Estess, P., and Siegelman, M.H. (1996). The route of antigen entry determines the requirement for L-selectin during immune responses. J. Exp. Med. 184, 2341-2351.
8. Cella, M., Sallusto, F., and Lanzavecchia, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16.
9. Cher, D.J., and Mosmann, T.R. (1987). Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 138, 3688-3694.
10. Colligan, J., Kruisbeck, A., Marguiles, D., Shevach, E., and Strober, W. (1994). Current Protocols in Immunology, R. Coico, ed. (NY: John Wiley and Sons).
11. Flynn, S., Toellner, K.M., Raykundalia, C., Goodall, M., and Lane, P. (1998). CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188, 297-304.
12. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C., and Nadler, L.M. (1991). B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579.
13. Gocinski, B.L., and Tigelaar, R.E. (1990). Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144, 4121-4128.
14. Godfrey, W.R., Fagnoni, F.F., Harara, M.A., Buck, D., and Engleman, E.G. (1994). Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 180, 757-762.
15. Grabbe, S., and Schwarz, T. (1998). Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37-44.
16. Grabbe, S., Steinbrink, K., Steinert, M., Luger, T.A., and Schwarz, T. (1995). Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155, 4207-4217.
17. Gramaglia, I., Weinberg, A.D., Lemon, M., and Croft, M. (1998). Ox40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 1617 6510-6517.
18. Hasbold, J., Johnson-Leger, C., Atkins, C.J., Clark, E.A., and Klaus, G.G. (1994). Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24, 1835-1842.
19. Higgins, L.M., McDonald, S.A., Whittle, N., Crockett, N., Shields, J.G., and MacDonald, T.T. (1999). Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162, 486-493.
20. Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., and Uchiyama, T. (1996). The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183, 2185-2195.
21. Imura, A., Hori, T., Imada, K., Kawamata, S., Tanaka, Y., Imamura, S., and Uchiyama, T. (1997). OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: Implication for the possible involvement of OX40 in leukemic cell infiltration. Blood 89, 2951-2958.
22. Kaleeba, J.A., Offner, H., Vandenbark, A.A., Lublinski, A., and Weinberg, A.D. (1998). The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells. Int. Immunol. 10, 453-461.
23. Kohler, G., and Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
24. Kondo, S., Beissert, S., Wang, B., Fujisawa, H., Kooshesh, F., Stratigos, A., Granstein, R.D., Mak, T.W., and Sauder, D.N. (1996). Hypo-responsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J. Investig. Dermatol. 106, 993-1000.
25. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
26. Lefkovits, I. (1997). Immunology Methods Manual (San Diego: Academic Press).
27. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E.R., Lyman, S.D., Shortman, K., and McKenna, H.J. (1996). Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962.
28. Miura, S., Ohtani, K., Numata, N., Niki, M., Ohbo, K., Ina, Y., Gojobori, T., Tanaka, Y., Tozawa, H., and Nakamura, M. (1991). Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol. Cell. Biol. 11, 1313-1325.
29. Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., and Delespesse, G. (1997). Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159, 3838-3848.
30. Ohshima, Y., Yang, L.P., Uchiyama, T., Tanaka, Y., Baum, P., Sergerie, M., Hermann, P., and Delespesse, G. (1998). OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92, 3338-3345.
31. Paterson, D.J., Jefferies, W.A., Green, J.R., Brandon, M.R., Corthesy, P., Puklavec, M., and Williams, A.F. (1987). Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 24, 1281-1290.
32. Rauschmayr-Kopp, T., Williams, I.R., Borriello, F., Sharpe, A.H., and Kupper, T.S. (1998). Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen. Eur. J. Immunol. 28, 4221-4227.
33. Schweitzer, A.N., and Sharpe, A.H. (1998). Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161, 2762-2771.
34. Simon, J.C., Mosmann, T., Edelbaum, D., Schopf, E., Bergstresser, P.R., and Cruz, P.D., Jr. (1994). In vivo evidence that ultraviolet B-induced suppression of allergic contact sensitivity is associated with functional inactivation of Th1 cells. Photodermatol. PhotoimMunol. Photomed. 10, 206-211.
35. Streilein, J.W., Toews, G.T., Gilliam, J.N., and Bergstresser, P.R. (1980). Tolerance or hypersensitivity to 2,4-dinitro-1 -fluorobenzene: The role of Langerhans cell density within epidermis. J. Investig. Dermatol. 74, 319-322.
36. Stuber, E., and Strober, W. (1996). The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183, 979-989.
37. Stuber, E., Neurath, M., Calderhead, D., Fell, H.P., and Strober, W. (1995). Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2, 507-521.
38. Tang, A., Judge, T.A., Nickoloff, B.J., and Turka, L.A. (1996). Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157, 117-125.
39. Thomson, J.A., Troutt, A.B., and Kelso, A. (1993). Contact sensitization to oxazolone: Involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses. Immunology 78, 185-192.
40. Titus, R.G., and Chiller, J.M. (1981). A simple and effective method to assess murine delayed type hypersensitivity to proteins. J. Immunol. Methods 45, 65-78.
41. Toews, G.B., Bergstresser, P.R., and Streilein, J.W. (1980). Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124, 445-453.
42. Vogel, L.A., and Noelle, R.J. (1998). CD40 and its crucial role as a member of the TNFR family. Semin. Immunol. 10, 435-442.
43. Weinberg, A.D., Bourdette, D.N., Sullivan, T.J., Lemon, M., Wallin, J.J., Maziarz, R., Davey, M., Palida, F., Godfrey, W., Engleman, E., et al. (1996). Selective depletion of myelin-reactive T cells with the anti-Ox-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2, 183-189.
44. Weinberg, A.D., Wegmann, K.W., Funatake, C., and Whitham, R.H. (1999). Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162, 1818-1826.
45. Xu, H., Dilulio, N.A., and Fairchild, R.L. (1996). T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4+ T cells. J. Exp. Med. 183, 1001-1012.